We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-7 of 7

Biomet Inc.

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • April 16 2012

Medical device company Biomet has agreed to pay more than $22 million to settle charges by the Securities and Exchange Commission (SEC) as well as parallel criminal charges by the U.S. Department of Justice (DOJ

Smith & Nephew

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • February 20 2012

The Securities and Exchange Commission (SEC) announced that it has reached a settlement with London-based medical device company Smith & Nephew PLC to resolve charges that the company violated the Foreign Corrupt Practices Act (FCPA) when its U.S. and German subsidiaries bribed public doctors in Greece for over a decade in order to win business

British pharmaceutical company AstraZeneca indicted in Serbia

  • Dorsey & Whitney LLP
  • -
  • Serbia
  • -
  • December 22 2011

AstraZeneca has been indicted for alleged bribery

Sciclone pharmaceuticals

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • November 18 2011

SciClone and certain of its directors and officers have agreed to settle the consolidated derivative lawsuits that were filed following the company’s announcement that it was being investigated by the Securities and Exchange Commission (SEC) and the Department of Justice (DOJ) for possible FCPA violations

Corruption digest

  • Dorsey & Whitney LLP
  • -
  • Netherlands, Poland
  • -
  • July 27 2011

An internal investigation has cleared Royal Philips Electronics NV’s headquarters in the Netherlands of involvement in an alleged bribery scheme in Poland, it has been reported

Pharmaceutical company changes policies ahead of the Bribery Act coming into force

  • Dorsey & Whitney LLP
  • -
  • United Kingdom
  • -
  • June 24 2011

AstraZeneca has announced that it has stopped the policy of paying for doctors to attend international medical conferences

Eli Lilly & Co

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • June 24 2011

In an effort to solicit members for a class action, two law firms that represent shareholders in class actions against publicly traded companies are investigating certain officers and directors of Eli Lilly